Immune-related pathogens (immune-targeting pathogens) directly infect or destroy host immune cells or disrupt immune regulatory pathways, which can trigger immune dysregulation, deficiency, or hyperactivation. They spread through blood, body fluids, mucosa, or cell-to-cell contact, causing acute infections as well as chronic or latent infections that raise the risk of opportunistic infections, malignancies, and autoimmune diseases.
iGeneTech combines proprietary TargetSeq® liquid-phase probe hybrid capture technology with bespoke microbial probe design to solve critical challenges such as viral mutation surveillance, low-abundance virus detection, and host tracing, and now offers multiple whole-genome kits for immune-related pathogens.
This curated set of capture panels targets high-priority immune-related pathogens with transparent reference metrics so laboratories can quickly gauge what data underlies each panel.
| Product Name | English Name | Taxonomy ID | Reference Genome Size | Reference Sequence Number | Number Of Probes |
|---|---|---|---|---|---|
| Monkeypox Virus Panel | Monkeypox virus | 10244 | 196.9 kb | 2442 | 40002 |
| HIV Panel | Human immunodeficiency virus 1 | 11676 | 9.2 kb | 34815 | 265045 |
| Human immunodeficiency virus 2 | 11709 | 10.4 kb | |||
| Cytomegalovirus Panel | Cytomegalovirus | 10358 | 235.6 kb | 422 | 130424 |
| Ebola Virus & Marburg Virus Panel | Ebola virus | 1570291 | 19 kb | 108 | 8543 |
| Marburg virus | 33727 | 19.1 kb | 4 |
Real-world capture performance highlights for select immunodeficiency-related targets.
Available catalog SKUs for the performance-highlighted panels.
| Product Name | 16 rxn | 96 rxn | Order |
|---|---|---|---|
| Monkeypox Virus Panel | PH2002641 | PH2002642 | |
| HIV Panel | PH2015081 | PH2015082 | |
| Cytomegalovirus Panel | PH2012941 | PH2012942 | |
| Ebola Virus & Marburg Virus Panel | PH2012951 | PH2012952 |
The Immunodeficiency Related Pathogens Panel enables simultaneous detection and identification of over 80 opportunistic pathogens from a single sample, specifically designed for immunocompromised patients at high risk for severe infections.
Targets pathogens that pose significant risk to transplant, oncology, and HIV/AIDS patients
Detects viruses, bacteria, fungi, and parasites commonly causing opportunistic infections
Complete genome capture enables drug resistance mutation detection and strain typing
Streamlined workflow delivers results within 24-48 hours for timely intervention
Key literature supporting the performance and applications of targeted pathogen capture sequencing.
Contact our team to learn more about the Immunodeficiency Related Pathogens Panel and how it can benefit your laboratory or clinical facility.